XML 81 R65.htm IDEA: XBRL DOCUMENT v3.23.4
Debt - Narrative (Details)
$ / shares in Units, shares in Millions
1 Months Ended 12 Months Ended
Feb. 28, 2023
USD ($)
Feb. 07, 2023
USD ($)
Apr. 08, 2021
USD ($)
$ / shares
shares
Apr. 30, 2021
USD ($)
day
Nov. 30, 2023
USD ($)
day
$ / shares
Nov. 30, 2022
USD ($)
Nov. 30, 2021
USD ($)
Aug. 31, 2022
Line of Credit Facility [Line Items]                
Payments of debt issuance costs             $ 9,900,000  
Number of shares subject to anti-dilution adjustments (in shares) | shares     6.3          
Capped call transactions (in dollars per share) | $ / shares     $ 89.88          
Represents premium price     100.00%          
Payments for derivative instrument     $ 43,100,000          
Decrease in additional paid in capital         $ (370,579,000) $ (331,650,000)    
Increase in retained earnings         120,858,000 101,656,000    
Decrease in deferred tax liabilities         (3,574,000) (4,628,000)    
Increase (decrease) in interest expense         5,747,000 5,712,000 $ 10,475,000  
Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06                
Line of Credit Facility [Line Items]                
Decrease in additional paid in capital         47,500,000      
Decrease in debt discount         56,000,000      
Increase in retained earnings         4,900,000      
Decrease in deferred tax liabilities         13,400,000      
Increase (decrease) in interest expense         $ (11,500,000) (11,500,000)    
Convertible Senior Notes | Convertible Debt                
Line of Credit Facility [Line Items]                
Debt instrument, face amount       $ 360,000,000        
Annual interest rate       1.00% 1.00%      
Payments of debt issuance costs           $ 10,800,000    
Common stock exceeds         130.00%      
Trading days | day         20      
Consecutive trading day | day         30      
Conversion ratio       0.0174525        
Initial conversion price (in dollars per share) | $ / shares         $ 57.30      
Repurchase price         100.00%      
Principal amount redeemable         $ 100,000,000      
Share price (in dollars per share) | $ / shares     $ 44.94          
Conversion option allocated to equity         64,800,000      
Debt instrument, interest rate, effective percentage           5.71%   1.63%
Convertible Senior Notes | Convertible Debt | Debt Instrument, Redemption, Period One                
Line of Credit Facility [Line Items]                
Common stock exceeds       130.00%        
Trading days | day       20        
Consecutive trading day | day       30        
Convertible Senior Notes | Convertible Debt | Debt Instrument, Redemption, Period Two                
Line of Credit Facility [Line Items]                
Common stock exceeds       98.00%        
Trading days | day       5        
Consecutive trading day | day       10        
Amended Credit Agreement | Revolving Line of Credit                
Line of Credit Facility [Line Items]                
Proceeds from lines of credit $ 195,000,000 $ 195,000,000            
Line of credit facility outstanding amount         $ 110,000,000